May 21, 2008 - Biosense Webster showed its 'Complete Ablation Solutions' portfolio at the Heart Rhythm Society's (HRS) ...
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management therapies under the new Vision 3D portfolio, which will comprise a full line of implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy-defibrillators (CRT-Ds), pacemakers and cardiac resynchronization therapy-pacemakers (CRT-Ps) to address the needs of p
May 21, 2008 - Physicians can detect and diagnose clinically actionable events earlier in pacemaker patients who utilize ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Quest International Inc. recently released its QMDL5PCX for patient monitoring and information management created for vital signs monitoring. The 15-inch patient monitor, with optional touchscreen, is reportedly suitable for any patient care environment and is virtually able to universally replace OEM specific displays even when specific, non-VESA timings are required.
May 21, 2008 — According to a new study released at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific ...
May 21, 2008 - Antiarrhythmic drug treatment during the six weeks following atrial fibrillation (AF) ablation is well ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 20, 2008 - Riata leads by St. Jude Medical showed very low adverse event rates for all categories of lead-related ...
Boston Scientific launched its FilterWire EZ Embolic Protection System in a new 2.25 – 3.5 mm size, designed to contain ...
May 20, 2008 – Volcano paid $12 million in cash at the closing for the acquisition of Novelis Inc., a privately-held ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 20, 2008 — GE Healthcare is expanding its strategic alliance with Biosense Webster to develop real-time ultrasound ...
Abbott's StarClose SE Vascular Closure System, a next-generation vessel closure device, is engineered to enable fast and secure closure of the femoral artery access site following a catheterization procedure.
May 20, 2008 - Boston Scientific launched its FilterWire EZ Embolic Protection System in a new 2.25 – 3.5 mm size ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 20, 2008 - There were no device-related events at 30 days follow-up of the first 13 patients in the OPEN I clinical ...
May 20, 2008 – Abbott launched the StarClose SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast and secure closure of the femoral artery access site following a catheterization procedure.
Medtronic lays out the first wave of cardiac rhythm disease management therapies under the new Vision 3D portfolio ...